BRANY announces the launch of Protocol Builder® 2.0, an advanced cloud-based tool for protocol writing, now enhanced with AI capabilities. Building on a decade of success, Protocol Builder has been w...
AI features simplify research protocol development, ensuring accuracy and compliance.
LAKE SUCCESS, N.Y.: BRANY announces the launch of Protocol Builder® 2.0, an advanced cloud-based tool for protocol writing, now enhanced with AI capabilities. Building on a decade of success, Protocol Builder has been widely used by institutions, biotech firms, and pharmaceutical companies.
Revolutionizing Research Protocol Development with AI
Protocol Builder 2.0 helps investigators develop comprehensive research protocols by intelligently guiding them through each step of protocol creation to ensure all critical components are addressed. The platform enhances the writing process and overall protocol quality by leveraging built-in guidance and AI features.
Key features include:
Empowering Investigators to Focus on Research
Protocol Builder 2.0 leverages AI to minimize administrative burden, allowing experienced and new researchers to focus on scientific innovation. This tech-enabled system supports the development of research protocols that meet regulatory and ethical standards, accelerating study start-up times.
“The future of protocol writing is here,” said Paddy Mullen, President and CEO at BRANY. “Protocol Builder 2.0 aligns with our mission to provide investigators with an intuitive, reliable tool that streamlines protocol development. AI-powered features enhance speed and compliance, benefiting researchers and patients.”
Customized for Institutional and Industry Needs
Protocol Builder 2.0 is customizable to reflect an organization’s unique protocol development processes and compliance guidelines. Licensing is available for institutions, biotech companies, and pharmaceutical organizations.
To learn more about Protocol Builder 2.0 and request a free demo, visit www.protocolbuilderpro.com or call (347)-510-0145.
About BRANY
BRANY is a national leader in IRB review and other clinical trial support services, providing solutions for academic medical centers, hospitals, investigators, and industry sponsors. BRANY offers a comprehensive suite of research compliance and operational support services, including IRB review, Medicare Coverage Analysis, clinical trial budgeting, and contracting. For more information, visit www.brany.com.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Keysight Technologies, Inc. (NYSE: KEYS) has enabled NIO to successfully validate the wireless systems in its smart electric vehicles using Keysight network…
#AI--Excelhire, the AI-powered hiring intelligence platform, proudly announces Balaji Karumanchi as its Founder and Chief Executive Officer. With a bold…
#AI--MangoBoost, a provider of cutting-edge system solutions for maximizing compute efficiency and scalability, has validated the scalability and efficiency…
Electronic Arts Inc. (NASDAQ: EA) and EA SPORTS™ today unveiled EA SPORTS™ Madden NFL 26, launching worldwide on August 14, 2025, for PlayStation®5, Xbox…